The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
CORONARY INTERVENTIONS
One-year outcomes in 1,010 unselected patients treated with the PROMUS Element everolimus-eluting stent: the multicentre PROMUS Element European Post-Approval Surveillance Study
EuroIntervention 2015;10:1267-1271 published online ahead of print January 2015. DOI: 10.4244/EIJY15M01_07
Martyn R. Thomas1*, MD, PhD; Ralf Birkemeyer2, MD; Peter Schwimmbeck3, MD, PhD; Victor Legrand4, MD, PhD; Raul Moreno5, MD; Carlo Briguori6, MD; Nikos Werner7, MD; Ezio Bramucci8, MD; Imre Ungi9, MD; Gert Richardt10, MD, PhD; Paul L. Underwood11, MD; Keith D. Dawkins11, MD
1. Guy’s and St. Thomas’ National Health Service Foundation Trust, London, United Kingdom; 2. Universitätsklinikum Rostock, Rostock, Germany; 3. Klinikum Leverkusen, Leverkusen, Germany; 4. Centre Hospitalier Universitaire Sart Tilman, Liege, Belgium; 5.
Aims: The PROMUS™ Element™ European Post-Approval Surveillance Study (PE-Prove) is aprospective, open-label, multicentre observational study designed to assess o